Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions
With more than 90 approved drugs by 2020, therapeutic antibodies have played a central role in shifting the treatment landscape of many diseases, including autoimmune disorders and cancers. While showing many therapeutic advantages such as long half-life and highly selective actions, therapeutic ant...
Saved in:
Main Authors: | Yu Tang (Author), Yanguang Cao (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs
by: Hua He, et al.
Published: (2019) -
Recent Advances in Translational Pharmacokinetics and Pharmacodynamics Prediction of Therapeutic Antibodies Using Modeling and Simulation
by: Kenta Haraya, et al.
Published: (2022) -
Physiological Considerations for Modeling in vivo Antibody-Target Interactions
by: Tyler Dunlap, et al.
Published: (2022) -
Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
by: Huixi Zou, et al.
Published: (2020) -
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
by: Karine Rodríguez-Fernández, et al.
Published: (2022)